How Validic solves the personal health data fragmentation problem that's quietly consuming your engineering capacity, threatening your data strategy, and holding your AI ambitions hostage.

Only 20% of CFOs Are Satisfied With Their Tech Investments

The 2024 Rimini Street Global Survey of nearly 3,000 CFOs and CIOs across industries revealed a striking number: only 20% of CFOs are satisfied with the business impact their technology investments have delivered. Four out of five CFOs — across sectors, geographies, and company sizes — feel that technology is not delivering adequate returns.

In healthcare, that dissatisfaction carries an additional weight. A failed CRM implementation is a write-down. A fragmented clinical data strategy means patients fall through gaps. A disconnected remote monitoring program means a readmission that cost $15,000 and could have been prevented for $150.

The stakes in health system technology investment are not just financial. They are clinical. And the CFOs who understand this — who can articulate the link between technology architecture and patient outcomes in the same breath as they discuss ROI — are the ones positioning their health systems to win in a value-based care world.

The Investment That Consistently Underdelivers

The same survey asked CFOs where their technology investments had delivered the least value. ERP upgrades and migrations ranked last — cited by 23% of CFOs as the lowest-value investment category. This aligns with what health system financial leaders experience repeatedly: the massive, multi-year ERP overhaul that consumes capital, disrupts operations, and delivers incremental improvement at best.

Meanwhile, the survey identified the three technology categories that delivered the most CFO-reported value:

• Security technologies (28%)

• Emerging technologies — AI, business intelligence, data analytics (27%)

• Customer-facing SaaS technologies like CRM (27%)

Notice the pattern. The highest-value investments share a common thread: they are closer to the patient and the revenue cycle, they generate actionable data, and they improve the organization's ability to manage risk and engage the populations it serves. In a health system context, this maps directly to personal health data — the layer of continuous, real-world patient data that sits between your EHR and the patient's daily life

What Personal Health Data Infrastructure Actually Delivers

Validic is the enterprise standard for personal health data — the platform that connects health systems to 700+ connected health devices and wearables, routes that data into the EHR, and enables care teams to act on it. For a health system CFO, the Validic investment thesis is grounded in three concrete financial levers.

Lever 1: Reducing Total Cost of Care

Health systems with active remote patient monitoring programs report measurable reductions in total cost of care. One Validic client saw more than $1,400 per patient per month reduction in total cost of care for patients enrolled in an intervention program. At scale, this is not a marginal financial improvement — it is a structural change to the cost base for managing complex chronic conditions.

Remote monitoring reduces unnecessary emergency department visits, prevents avoidable readmissions, and enables earlier clinical intervention before conditions escalate. These are not soft benefits. They show up in the claims data.

Lever 2: Clinical Outcomes That Drive Quality Payments

In a value-based care environment, clinical outcomes are revenue. Validic-powered programs have demonstrated:

• An average 12% drop in systolic blood pressure in six weeks for hypertension patients — moving from Stage 2 hypertension to normal range

• An average 2.3-point HbA1c reduction in 90 days for diabetic patients with levels above 9

• Care teams saving 8 hours per provider per week by focusing high-touch resources on patients who need them

These outcomes are the inputs to quality metrics, HEDIS scores, and value-based contract performance. Your payer contracts increasingly reward exactly this kind of population-level health management. The CFO who understands that a blood pressure outcome improvement translates to a quality bonus understands the real ROI model.

Lever 3: Maximizing EHR Investment Already on the Books

Every health system has already made a significant EHR investment. Epic implementations alone represent hundreds of millions of dollars in capital and ongoing operational cost. One of the most consistent complaints in health system technology circles is that the EHR investment is not being fully utilized — particularly for remote and chronic care.

Validic's architecture is designed to maximize your existing EHR investment, not compete with it. Validic Impact runs fully embedded inside Epic, with real-time flowsheet writes, provider inbasket alerts, and generative AI summaries delivered within the clinical workflow your teams already use. This means your EHR spend — already on the books — now extends to the patient's home, covering 24-hour data streams from wearables and clinical devices, without requiring a separate application or additional IT build.

The ROI calculus is straightforward: more clinical utility from an existing capital investment, at marginal incremental cost.

The CFO's Role in Positioning the Health System for the Future

The Rimini Street survey found something important about the evolution of the CFO role: 66% of CFOs now consider themselves responsible for underlying technology decisions — not just budget approval, but the technology choices themselves. This is partly because CFOs are frustrated with the returns they're seeing. But it also reflects a more fundamental shift: in healthcare, financial strategy and clinical strategy are converging.

The health systems that will perform best over the next decade — financially and clinically — are those that can manage population health at scale. That means continuous data on chronic condition patients between visits. It means remote monitoring programs that prevent the high-cost events that erode margins. It means AI-powered clinical decision support that helps care teams prioritize their time. All of it depends on the same foundation: a reliable, scalable personal health data layer.

This is not a technology trend. It is the infrastructure of modern care delivery. And the CFO's job is to fund it intelligently.

The CFO/CIO Partnership Is the Key Unlock

The same survey found that 86% of CFOs and CIOs report their relationship has strengthened — driven largely by shared security concerns and the pressure to make smarter technology decisions in a tighter budget environment. But 85% of CFOs also said they want CIOs who are more business-savvy, and 86% of CIOs want CFOs who are more technology-literate.

The health system CFO who can speak fluently about remote monitoring economics — who understands why a unified personal health data platform is a better investment than a portfolio of point solutions, and who can connect device data to HEDIS scores to value-based contract performance — is the CFO who can have a truly productive conversation with their CIO about where to invest.

The question is no longer whether remote patient monitoring and personal health data are part of the care delivery model. CMS reimbursement policy has settled that. One national health system alone has enrolled more than 500,000 patients in a remote care program powered by a single unified platform. The question is whether your health system will build that capability on a fragmented foundation of one-off integrations, or on the enterprise standard.

The Investment Decision

Validic is not a point solution. It is the data infrastructure layer that makes every other health technology investment work better — your EHR, your AI initiatives, your population health analytics, your value-based care programs. It connects 600+ devices through a single integration, runs inside your existing Epic instance, saves care teams 8 hours per provider per week, and has demonstrated clinical outcomes that translate directly to quality payment performance.

For the health system CFO evaluating where to put technology dollars in an environment of rising IT costs and intensifying pressure for ROI: the personal health data layer is not a nice-to-have. It is the connective tissue between the care delivery infrastructure you've already built and the outcomes your organization is now being held financially accountable for delivering.

The 20% of CFOs who are satisfied with their technology investments have something in common: they've moved beyond the technology trend conversation and started investing in infrastructure that creates durable competitive advantage. In healthcare, that infrastructure is patient data — continuous, real-world, and connected.

Validic is where that starts.